Literature DB >> 22201614

The penetration of renal mass biopsy in daily practice: a survey among urologists.

Kurdo Barwari1, Jean J de la Rosette, M Pilar Laguna.   

Abstract

BACKGROUND AND
PURPOSE: The vast increase in recent publications on renal mass biopsy (RMB) suggests an increased interest in the subject. The objective of the survey was to assess the use of RMB in current urologic practice, including related factors such as indications and patterns in practice.
METHODS: The link to a web-based questionnaire ( www.surveymonkey.com ) was sent to all registered e-mail addresses (1854) of members of the Endourological Society in December 2010. The questionnaire contained six epidemiologic questions, 10 regarding patterns of practice, one regarding the influence of the literature, and one on future techniques. Chi-square test (for trends) was used to assess statistical significant differences among categorical answers.
RESULTS: In total, 190 responders completed the survey of whom 73% indicated performing RMB "never" or "rarely" compared with 9% performing RMB in 25% to 100% of cases. Thirteen percent of responders reported never to take a RMB. Of the latter, significantly fewer practice in university hospitals (6% vs 20%-30%, P=0.003). Main indications to perform RMB are still tumors in solitary/transplant kidneys and in metastatic disease. Lack of influence on clinical management and risk of false negatives were the main reasons not to perform biopsies. Sixty-one percent prefer histological biopsies compared with 8% who prefer cytological aspiration; 31% indicated that they combine both techniques. Other tissue differentiation techniques (Optical Coherence Tomography, Raman-spectroscopy) are unknown to 65% of urologists.
CONCLUSION: RMB is not yet applied widely in urologic practice, with academic urologists performing RMB less infrequently. Core biopsies are still preferred, although combined with cytologic punctures by a considerable number of responders.

Entities:  

Mesh:

Year:  2012        PMID: 22201614     DOI: 10.1089/end.2011.0407

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  8 in total

1.  Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses.

Authors:  Patrick O Richard; Lisa Martin; Luke T Lavallée; Philippe D Violette; Maria Komisarenko; Andrew J Evans; Kunal Jain; Michael A S Jewett; Antonio Finelli
Journal:  Can Urol Assoc J       Date:  2018-04-06       Impact factor: 1.862

Review 2.  Should Small Renal Masses Be Biopsied?

Authors:  Ricardo R N Leão; Ardalan E Ahmad; Patrick O Richard
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

3.  The accuracy of renal tumor biopsy: analysis from a national prospective study.

Authors:  J C Bernhard; P Bigot; G Pignot; H Baumert; L Zini; H Lang; M Crepel; P Monod; L Salomon; L Bellec; M Roupret; M Schneider; E Xylinas; P Paparel; F Bruyere; J Berger; J P Ansieau; P Gimel; F Salome; C Castagnola; C Pfister; J M Legraverend; M O Timsit; L Le Pellec; J L Auberget; E Rolland; R Mallet; A Mejean; J J Patard
Journal:  World J Urol       Date:  2014-11-06       Impact factor: 4.226

Review 4.  Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation.

Authors:  Alejandro Sanchez; Adam S Feldman; A Ari Hakimi
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

5.  Feasibility and Outcomes of Renal Mass Biopsy for Anatomically Complex Renal Tumors.

Authors:  Selma Masic; Marshall Strother; Laura C Kidd; Brian Egleston; Avery Braun; Abhishek Srivastava; Marc Smaldone; Barton Milestone; Rosaleen Parsons; Rosalia Viterbo; Richard Greenberg; David Chen; Alexander Kutikov; Robert Uzzo
Journal:  Urology       Date:  2021-08-08       Impact factor: 2.633

Review 6.  Liquid biopsy: a step forward towards precision medicine in urologic malignancies.

Authors:  Ashley Di Meo; Jenni Bartlett; Yufeng Cheng; Maria D Pasic; George M Yousef
Journal:  Mol Cancer       Date:  2017-04-14       Impact factor: 27.401

Review 7.  Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma.

Authors:  Yan Wu; Young Suk Kwon; Mina Labib; David J Foran; Eric A Singer
Journal:  Dis Markers       Date:  2015-11-01       Impact factor: 3.434

8.  Update on the types and usage of liquid biopsies in the clinical setting: a systematic review.

Authors:  Borros Arneth
Journal:  BMC Cancer       Date:  2018-05-04       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.